We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Public Health England (PHE)
has advised that GSK is confident that planned supplies of adult and paediatric hepatitis B vaccine (Engerix B®) are now sufficient to supply the UK market.
PHE have agreed to accelerate the phased re-introduction of hepatitis B vaccine outlined in the recovery plan, so that vaccine is now available for all priority groups 1 to 4.
This means that:
To prevent excessive stockpiling and to ensure backlog or catch up vaccination can continue, some ordering restrictions will remain in place. If a vaccine order cannot be fulfilled by one manufacturer, please check with another.
